Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePeptide Receptor Radionuclide Therapy with <sup>67</sup>Cu-CuSarTATE is Highly Efficacious Against a Somatostatin Positive Neuroendocrine Tumor Model.AuthorsCullinane, Carleen; Jeffery, Charmaine M.; Roselt, Peter D.; van Dam, Ellen M.; Jackson, Susan; Kuan, Kevin; Jackson, Price; Binns, David; Zuylekom, Jessica van; Harris, Matthew J.; Hicks, Rodney J.; Donnelly, Paul S.PublicationJournal of Nuclear Medicine, 2020, Vol 61, Issue 6, p1ISSN0161-5505Publication typeArticleDOI10.2967/jnumed.120.243543